Basic Information
In addition to growing cannabis for Canada's direct-to-consumer retail cannabis market, FSD Pharma is now developing a new cannabinoid-based therapy for the treatment of various central nervous system disorders, chronic pain, fibromyalgia, irritable bowel syndrome, and several other conditions.